|
Volumn 3, Issue 4, 2018, Pages
|
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway
a a a b c c d e e f a,b g a a,h |
Author keywords
Cancer; Hematology; Hematopoietic stem cells
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA BINDING PROTEIN;
ONCOPROTEIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE INHIBITOR;
STEM CELL FACTOR RECEPTOR;
TET2 PROTEIN, MOUSE;
ANIMAL;
BONE MARROW CELL;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CELL TRANSFORMATION;
DISEASE MODEL;
DNA METHYLATION;
DRUG EFFECT;
GAIN OF FUNCTION MUTATION;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION;
GENE KNOCK-IN;
GENETIC EPIGENESIS;
GENETICS;
HUMAN;
KNOCKOUT MOUSE;
MAST CELL;
MASTOCYTOSIS;
METABOLISM;
MOUSE;
PATHOLOGY;
PHYSIOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CELL TRANSFORMATION, NEOPLASTIC;
DISEASE MODELS, ANIMAL;
DNA METHYLATION;
DNA-BINDING PROTEINS;
EPIGENESIS, GENETIC;
GAIN OF FUNCTION MUTATION;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE KNOCK-IN TECHNIQUES;
HUMANS;
MAST CELLS;
MASTOCYTOSIS;
MICE;
MICE, KNOCKOUT;
MYELOID CELLS;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-KIT;
|
EID: 85057975637
PISSN: None
EISSN: 23793708
Source Type: Journal
DOI: 10.1172/jci.insight.94679 Document Type: Article |
Times cited : (19)
|
References (0)
|